Subscribe to our newsletter to receive the latest product updates and special offers

Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

Last Close
Jul 22 10:41AM ET
Dollar change
Percentage change
IndexRUT P/E13.83 EPS (ttm)0.30 Insider Own3.24% Shs Outstand73.53M Perf Week-2.31%
Market Cap310.68M Forward P/E- EPS next Y-0.15 Insider Trans0.00% Shs Float71.56M Perf Month-7.48%
Income22.85M PEG0.69 EPS next Q-0.01 Inst Own94.31% Short Float3.10% Perf Quarter-20.44%
Sales304.64M P/S1.02 EPS this Y-122.58% Inst Trans-4.29% Short Ratio1.79 Perf Half Y-46.01%
Book/sh5.76 P/B0.73 EPS next Y9.79% ROA4.93% Short Interest2.22M Perf Year-4.53%
Cash/sh3.57 P/C1.18 EPS next 5Y20.00% ROE5.57% 52W Range3.91 - 8.45 Perf YTD-48.77%
Dividend Est.- P/FCF2.31 EPS past 5Y17.20% ROI5.23% 52W High-50.29% Beta0.10
Dividend TTM- Quick Ratio10.49 Sales past 5Y20.54% Gross Margin42.89% 52W Low7.30% ATR (14)0.18
Dividend Ex-Date- Current Ratio11.97 EPS Y/Y TTM-22.10% Oper. Margin4.98% RSI (14)43.85 Volatility4.62% 4.11%
Employees638 Debt/Eq0.03 Sales Y/Y TTM-35.83% Profit Margin7.50% Recom2.67 Target Price6.35
Option/ShortYes / Yes LT Debt/Eq0.03 EPS Q/Q-113.18% Payout0.00% Rel Volume0.13 Prev Close4.20
Sales Surprise3.57% EPS Surprise- Sales Q/Q-65.07% EarningsMay 08 AMC Avg Volume1.24M Price4.20
SMA20-0.71% SMA50-8.17% SMA200-31.66% Trades Volume36,978 Change0.01%
Date Action Analyst Rating Change Price Target Change
Jan-03-23Resumed Evercore ISI In-line $5
Sep-22-21Downgrade Raymond James Outperform → Mkt Perform
Aug-21-20Initiated Evercore ISI Outperform $22
Aug-10-20Initiated JP Morgan Neutral $18
Aug-10-20Initiated Citigroup Buy $18
Aug-07-20Upgrade Raymond James Mkt Perform → Outperform $16
Jun-25-20Initiated Lake Street Buy $19
Apr-21-20Resumed Stephens Equal-Weight $14
Oct-23-18Resumed Raymond James Mkt Perform
Jul-16-18Downgrade Stephens Overweight → Equal-Weight
Jun-27-24 07:05AM
Jun-07-24 06:09PM
May-13-24 10:47AM
May-10-24 03:04PM
May-09-24 01:54PM
08:29AM Loading…
May-08-24 08:57PM
Apr-22-24 08:00AM
Apr-18-24 11:30AM
Mar-21-24 08:31AM
Feb-28-24 09:23AM
08:55AM Loading…
Feb-27-24 05:11PM
Feb-13-24 04:05PM
Feb-01-24 06:42PM
Jan-04-24 07:05AM
Dec-22-23 05:01AM
Nov-27-23 09:55AM
Nov-13-23 04:15PM
Nov-09-23 11:12AM
Nov-08-23 12:14PM
Nov-07-23 06:50PM
04:59PM Loading…
Oct-23-23 04:05PM
Aug-09-23 06:02AM
Aug-05-23 08:52AM
Aug-04-23 11:45AM
Aug-03-23 05:55PM
Jul-20-23 04:05PM
Jun-29-23 07:07AM
Jun-21-23 08:00PM
Jun-13-23 04:05PM
Jun-08-23 11:03AM
Jun-01-23 06:29AM
May-16-23 06:08AM
May-12-23 07:12AM
May-11-23 11:03AM
May-10-23 05:35PM
May-03-23 07:05AM
Apr-26-23 08:00PM
Apr-21-23 09:40AM
Apr-05-23 08:38AM
Mar-29-23 07:30AM
Mar-21-23 07:22AM
Mar-20-23 07:20AM
Mar-08-23 11:53AM
Feb-23-23 12:20PM
Feb-16-23 04:38PM
Feb-15-23 03:48PM
Feb-14-23 06:05PM
Feb-07-23 07:05AM
Dec-21-22 07:52AM
Dec-01-22 07:05AM
Nov-14-22 07:05AM
Nov-08-22 06:05PM
Nov-03-22 09:15AM
Nov-02-22 07:05AM
Nov-01-22 07:05AM
Oct-07-22 09:14AM
Oct-01-22 10:30AM
Sep-28-22 10:28AM
Sep-20-22 04:05PM
Sep-14-22 07:05AM
Aug-31-22 06:29AM
Aug-14-22 08:28AM
Aug-09-22 07:25PM
Aug-02-22 07:05AM
Jul-28-22 07:05AM
Jul-14-22 08:42AM
Jun-14-22 08:31AM
Jun-08-22 04:05PM
May-25-22 07:05AM
May-23-22 04:05PM
May-17-22 07:05AM
May-10-22 06:55PM
May-04-22 06:45PM
May-03-22 04:05PM
Apr-24-22 10:21AM
OraSure Technologies, Inc. engages in the development, manufacture, and distribution of point of care diagnostic tests and molecular collection devices designed to detect or diagnose critical medical conditions. It operates through the OSUR and DNAG segments. The OSUR segment offers oral fluid diagnostic products and specimen collection devices. The DNAG segment produces specimen collection kits that are used to collect, stabilize, transport, and store samples of genetic material for molecular testing in the consumer genetic, clinical genetic, academic research, pharmacogenomics, personalized medicine, microbiome, and animal genetics markets. The company was founded by Michael J. Gausling in 2000 in and is headquartered in Bethlehem, PA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Weber Kathleen GallagherChief Product OfficerDec 19 '23Option Exercise5.714,12923,597278,829Dec 21 04:04 PM
Weber Kathleen GallagherChief Product OfficerDec 19 '23Sale8.0524,129194,219254,700Dec 21 04:04 PM
Anthony Michele MarieSVP Finance & CAOAug 15 '23Option Exercise5.711,75810,03887,946Aug 17 04:27 PM
Anthony Michele MarieSVP Finance & CAOAug 15 '23Sale6.501,75811,42786,188Aug 17 04:27 PM